Publisher of leading Seniors’ website urges
embrace of prescription meds importation
as ‘stimulus’ to implement personal, Federal savings

St. Louis, MO, July 11, 2011—Taking steps to cut medical costs for individuals and governmental agencies by the use of personal importation of prescription medicines from licensed, registered pharmacies in Tier One countries outside the United States could  provide a first step towards relieving the budgetary impasse says the publisher of a leading informational website for aging issues.

Daniel Hines, publisher of www.TodaysSeniorsNetwork.com, and other sites dedicated to advocacy for successful and healthy aging, has been an advocate for more than 10 years for personal importation of safe, affordable prescription medicines from Tier One Countries whose standards of oversight and efficacy meet or exceed those of the United States.

(To read the blog about the case for personal importation, go to http://RxforAmericanHealth.blogspot.com)

“It is interesting to note that recently there was a story about how PhRMA, the lobbying arm of the Pharmaceutical industry, is seeking to block deficit talk demands for Discounts of prescription medicine prices,” Hines says.  “PhRMA’s concern is indicative of the fact that growing numbers of policy makers and Americans are realizing that the continued and growing cost of brand-name medicines has been and will continue to be a major driver of health care costs in the U.S., and that the burden of those costs is a major reason for our fiscal crisis.”

He notes that personal importation of brand-name medicines could result in savings of as much as 60 to 80 percent when compared to the cost of the same medicines sold in the U.S.

“This is another example in which the American public is ahead of our elected leadership,” Hines continues.  “There is a proven record of safety, efficacy and enhanced health and well-being thanks to more than a decade ago Americans embraced personal importation of safe, affordable prescription medicines.

“PhRMA has used scare tactics over the years, ranging from ‘safety’ to counterfeiting to reduced ‘R&D’ and is now claiming the loss of hundreds of thousands of jobs and revenue if its pricing schemes are deterred. It has colluded with governmental agencies in the unwarranted seizures of vital medicines.

“The fact is that even with its behind closed door deals, untold numbers of elderly Americans and a growing number of families simply must restrict their access to vital medicines,” Hines says. 

“It is now time for Congress and the Administration to embrace personal importation as a step towards reducing the cost of healthcare by allowing Americans to exercise their right and ability to make individual healthcare decisions and enjoy the health and fiscal benefits that at this time can be best provided by personal importation of prescription medicines from proven safe sources and services outside the U.S.”